Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Res. 1994 Mar 1;54(5):1135-8.

Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3.

Author information

  • 1Division of Oral Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.


Mucositis is a common, dose-limiting complication in patients receiving cancer chemotherapy, which appears to be a consequence of the rate of epithelial proliferation. The beta transforming growth factors have been shown to be negative regulators of epithelial cell proliferation. Here we show that transforming growth factor beta 3 administration reduced proliferation of oral epithelium in vitro and in vivo. Topical application of transforming growth factor beta 3 to the oral mucosa of the Syrian golden hamster prior to chemotherapy significantly reduced the incidence, severity, and duration of oral mucositis, reduced chemotherapy-associated weight loss, and increased survival.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk